The markets closed higher with the Dow gaining 39 points to 22,370 as investors await the Federal Reserve's concluding statement. Nasdaq rose 6 points to 6,46.
On the upside
Shares of Veritone (Nasdaq: VERI) climbed for the fourth day.
President Donald Trump may ease restrictions on gun sales to foreign buyers which sent shares of Sturm, Ruger & Co. (NYSE: RGR) soaring.
Rumors swirled that Chicago Bridge & Iron (NYSE: CBI) may be acquired.
On the downside
Siris Capital Group ended its efforts to acquire Synchronoss Technologies (Nasdaq: SNCR).
Supernus Pharmaceuticals (Nasdaq: SUPN) has eliminated a lower dose option of its Phase 3 clinical trial of SPN-810 to treat impulsive aggression in patients aged 6 to 12 years who have attention deficit hyperactivity disorder.
MediWound (Nasdaq: MDWD) priced its public offering of 4.4 million common shares at the discounted price of $5.00 per share.
In the broad market, advancing issues outpaced decliners by a margin of nearly 6 to 5 on the NYSE while advancers barely edged out decliners by a slim margin on Nasdaq. The broader S&P 500 added 2 points to 2,506. Bitcoin plummeted $177 to $3,890.
